LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 211,600 shares, a drop of 34.3% from the March 15th total of 322,100 shares. Currently, 1.5% of the company’s stock are sold short. Based on an average daily volume of […]
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 9,200 shares, an increase of 15.0% from the December 31st total of 8,000 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average trading […]
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) was the recipient of a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 21,800 shares, a decline of 25.3% from the October 15th total of 29,200 shares. Approximately 0.2% of the shares of the company are sold […]
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) was the recipient of a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 37,900 shares, a decrease of 15.0% from the August 31st total of 44,600 shares. Currently, 0.3% of the shares of the company are short […]
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) and Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk. Earnings & Valuation This table compares LAVA […]